InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 2

Friday, 09/11/2020 9:43:45 PM

Friday, September 11, 2020 9:43:45 PM

Post# of 148
At AACR the company showed that an optimised Cas9 gene editing system could successfully disrupt TGFbR2 and CISH. Knockout of the former made CAR-NK cells resistant to TGF-b mediated inhibition of cancer cell killing. For the latter KO CAR-NK cells had improved proliferation, survival, cytokine production and cancer cell killing. The findings showed that gene editing could be combined with CAR engineering to enhance NK cell function and resist the inhibitory tumour microenvironment https://www.nkartatx.com/file.cfm/75/docs/Nkarta_AACR_2020_gene_editing_891_20.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News